The effect of information about the benefits and harms of mammography on women’s decision-making: study protocol for a randomized controlled trial

dc.contributor.authorCarles Lavila, Misericòrdia
dc.contributor.authorMartínez Alonso, Montserrat
dc.contributor.authorPons Rodríguez, Anna
dc.contributor.authorPérez Lacasta, María José
dc.contributor.authorPerestelo Pérez, Lilisbeth
dc.contributor.authorSala, Maria
dc.contributor.authorVidal Lancis, Maria Carmen
dc.contributor.authorGarcía Martínez, Montserrat
dc.contributor.authorToledo Chávarri, Ana
dc.contributor.authorCodern Bové, Núria
dc.contributor.authorFeijoo Cid, Maria
dc.contributor.authorRomero, Anabel
dc.contributor.authorPla, Roger
dc.contributor.authorSoler Gonzalez, Jorge
dc.contributor.authorCastells, Xavier
dc.contributor.authorRué, Montserrat
dc.date.accessioned2018-09-05T07:01:01Z
dc.date.available2018-09-05T07:01:01Z
dc.date.issued2017-09-12
dc.date.updated2018-07-24T12:01:12Z
dc.description.abstractBackground: The decision to participate or not in breast cancer screening is complex due to the trade-off between the expected benefit of breast cancer mortality reduction and the major harm of overdiagnosis. It seems ethically necessary to inform women so that they can actively participate in decision-making and make an informed choice based on their values and preferences. The objective of this study is to assess the effects of receiving information about the benefits and harms of screening on decision-making, in women approaching the age of invitation to mammography screening. Methods: A two-stage, randomized controlled trial (RCT). In the first stage, 40 Basic Health Areas (BHAs) will be selected and randomized to intervention or control. In the second stage, women within each BHA will be randomly selected (n = 400). Four breast cancer screening programs (BCSPs) of the Spanish public health system, three in Catalonia and one in the Canary Islands will participate in the study. Women in the intervention arm will receive a leaflet with detailed information on the benefits and harms of screening using mammography. Women in the control arm will receive a standard leaflet that does not mention harms and recommends accepting the invitation to participate in the biennial examinations of the BCSP. The primary outcome is informed choice, a dichotomous variable that combines knowledge, attitudes, and intentions. Secondary outcomes include decisional conflict; confidence in the decision made; anxiety about screening participation; worry about breast cancer; anticipated regret; time perspective; perceived importance of benefits/ harms of screening; perceived risk of breast cancer; and leaflet acceptability. Primary and secondary outcomes are assessed 2-3 weeks after the intervention. Discussion: This is the first RCT that assesses the effect of informing about the benefits and harms of breast cancer screening in Spain in women facing the decision to be screened using mammography. It aims to assess the impact of information on several decisional outcomes and to contribute to paving the road towards shared decision-making in breast cancer screening in our country.
dc.format.extent8 p.
dc.format.mimetypeapplication/pdf
dc.identifier.pmid28899412
dc.identifier.urihttps://hdl.handle.net/2445/124272
dc.language.isoeng
dc.publisherBioMed Central
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1186/s13063-017-2161-7
dc.relation.ispartofTrials, 2017, vol. 18, num. 426
dc.relation.urihttps://doi.org/10.1186/s13063-017-2161-7
dc.rightscc by (c) Carles et al., 2017
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationCàncer de mama
dc.subject.classificationCribratge
dc.subject.otherBreast cancer
dc.subject.otherMedical screening
dc.titleThe effect of information about the benefits and harms of mammography on women’s decision-making: study protocol for a randomized controlled trial
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
CarlesM.pdf
Mida:
505.66 KB
Format:
Adobe Portable Document Format